PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: DeltaTRAK

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DeltaTRAK Introduces Innovative Pathogen Screening Technology to Pharmceutical Industry at PDA Annual Meeting - Deltatrak® to showcase bacterial enzyme detection technology at 6th annual global conference on pharmaceutical microbiology - DeltaTRAK.com
DeltaTRAK Introduces Innovative Pathogen Screening Technology to Pharmceutical Industry at PDA Annual Meeting

 

NewswireToday - /newswire/ - Pleasanton, CA, United States, 2011/10/05 - Deltatrak® to showcase bacterial enzyme detection technology at 6th annual global conference on pharmaceutical microbiology - DeltaTRAK.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

DeltaTRAK®, a leading innovator of cold chain management solutions and bacteria detection technologies for the pharmaceutical industry, today announced it plans to showcase the DeltaTRAK FlashCheck bacterial enzyme detection systems at its booth (#31) at the Parenteral Drug Associations' 6th Annual Global Conference on Pharmaceutical Microbiology in Bethesda, Maryland October 17 through 18, 2011. The bacterial enzyme detection systems include the FlashCheck Real-Time Bacterial Enzyme Detection system and FluoreCheck Assay system designed to be used with a digital handheld fluorometer. Both systems can be used as general screening tests. The FluoreCheck Assay system can also be used to identify specific strains of harmful bacteria in liquids or emulsified samples from surfaces of equipment. Using the bacterial enzyme detection systems will allow pharmaceutical manufacturers to identify the presence of bacteria in their manufacturing facility in as little as 20 minutes.

"Bacteria in any manufacturing facility are a serious problem and it is particularly imperative in clean rooms where injectable or oral medicines are being produced," said Frederick Wu, president and CEO of DeltaTRAK. "Using enzyme detection technology for identifying bacteria on site provides an accurate, quick and inexpensive way to screen for dangerous levels of bacterial contamination."

DeltaTRAK's bacterial enzyme technology uses proprietary substrates with bacterial enzymes that when bonded and hydrolyzed (introduced to water) create a chemical reaction. This reaction breaks the substrate into two parts. One of these parts (the tag) releases energy in the form of fluorescence. The tag's fluorescence can be seen when excited by an external source within a digital handheld fluorometer or by using reagents that provide visual, colorimetric results on a swab or test strip. Utilizing DeltaTRAK's bacterial enzyme detection assays allows users to screen for the presence of bacteria on surfaces, equipment, or in water and beverages.

The DeltaTRAK FlashCheck® Real-Time Bacterial Enzyme Detection kits include two models for testing equipment surfaces. The models are:

• Real-Time Surface Assays (equipment) for total organisms- model 50025
• Real-Time Surface Assays (equipment) for gram negative bacteria- model 50026

The FluoreCheck system includes the following assays for total organisms, gram negative bacteria or specific pathogens:

• Total Organism
• Gram Negative Bacteria
• E. coli
• Enterococcus
• S. aureus
• Fecal Coloforms
• Salmonella
• Listeria** available soon.

About DeltaTRAK®
DeltaTRAK® (deltatrak.com) is a leading innovator of cold chain management solutions and bacteria detection technologies for the pharmaceutical industry. The company's cold chain management solutions include a wide range of temperature, humidity, and pH monitoring and recording devices, such as data loggers, wireless systems, and a variety of professional thermometers. DeltaTRAK's bacterial contamination detection solutions include cutting-edge bacterial enzyme detection technology for field testing of water, equipment and surfaces. Headquartered in Pleasanton, California, DeltaTRAK has an R&D facility in San Diego, California, a manufacturing and distribution facility in Modesto, California, and an electronic assembly plant in Shenzhen, China.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: DeltaTRAK

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DeltaTRAK Introduces Innovative Pathogen Screening Technology to Pharmceutical Industry at PDA Annual Meeting

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Val Cureton - DeltaTRAK.com 
1-800-962-6776 marketing[.]deltatrak.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any DeltaTRAK securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From DeltaTRAK / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)